Wed, February 20, 2019
[ Wed, Feb 20th 2019 ]: WOPRAI
George Bahamondes Downgraded (ABR) to Hold on, Feb 20th, 2019
Tue, February 19, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Paul Coster Downgraded (TPIC) to Hold and Held Target at $35 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Michael Baker Downgraded (ULTA) to Hold and Increased Target to $311 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Philip Cusick Downgraded (UNIT) to Sell and Decreased Target to $16 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Frank Louthan Downgraded (UNIT) to Hold on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Gregory Williams Downgraded (UNIT) to Hold on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Allison Landry Maintained (XPO) at Buy with Decreased Target to $70 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Stephanie Benjamin Maintained (XPO) at Strong Buy with Decreased Target to $65 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Ravi Shanker Downgraded (XPO) to Hold and Decreased Target to $71 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Tobey Sommer Downgraded (CCRN) to Hold on, Feb 19th, 2019
Fri, February 15, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Myles Walton Downgraded (B) to Hold and Decreased Target to $65 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Jacob Kilstein Downgraded (AIG) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Michael Schmidt Upgraded (AGIO) to Buy and Held Target at $80 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Derrick Wood Upgraded (WDAY) to Buy and Increased Target to $225 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Nehal Chokshi Upgraded (SMCI) to Strong Buy and Held Target at $3.8 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Haendel St. Juste Downgraded (SPG) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Lee Krowl Downgraded (TRUE) to Hold and Decreased Target to $9.5 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Shweta Khajuria Downgraded (TRUE) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Robert Drbul Downgraded (TPX) to Hold on, Feb 15th, 2019
Thu, February 14, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Wendy Nicholson Maintained (TAP) at Strong Buy with Decreased Target to $69 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Vamil Divan Maintained (TEVA) at Hold with Decreased Target to $20 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Elliot Wilbur Upgraded (TEVA) to Buy on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Jeff Van Sinderen Initiated (CDXC) at Strong Buy and Held Target at $7 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Paul Bieber Maintained (YELP) at Buy with Increased Target to $59 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Brian Nowak Maintained (YELP) at Sell with Increased Target to $31 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Mark May Downgraded (YELP) to Hold on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Alex Rygiel Maintained (TMHC) at Hold with Increased Target to $21 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Ryan Nash Upgraded (SYF) to Strong Buy on, Feb 14th, 2019
Wed, February 13, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Christopher York Maintained (ARCC) at Buy with Increased Target to $20 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Mark Delaney Upgraded (APTV) to Strong Buy on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Jeffrey Silber Maintained (BFAM) at Hold with Increased Target to $122 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Glenn Chin Initiated (AN) at Hold on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Mark Mahaney Maintained (AKAM) at Hold with Decreased Target to $76 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
James Fish Maintained (AKAM) at Buy with Increased Target to $85 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Sameet Sinha Maintained (AKAM) at Strong Buy with Decreased Target to $102 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Keith Weiss Maintained (AKAM) at Buy with Increased Target to $80 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Brandon Nispel Maintained (AKAM) at Buy with Increased Target to $76 on, Feb 13th, 2019
Tue, February 12, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Gerrick Johnson Downgraded (TTWO) to Sell on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Chad Bennett Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Yun Kim Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Greg McDowell Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Gur Talpaz Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Brandon Nispel Maintained (AMT) at Buy with Increased Target to $180 on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Dan Leonard Maintained (A) at Strong Buy with Increased Target to $85 on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Increased Target to $69 on, Feb 12th, 2019
Mon, February 11, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Jeffrey Silber Maintained (TBI) at Hold with Decreased Target to $24 on, Feb 11th, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Ronald Epstein Upgraded (TGI) to Strong Buy and Increased Target to $35 on, Feb 11th, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Sarah Akers Maintained (SRE) at Buy with Increased Target to $64 on, Feb 11th, 2019

Elliot Wilbur Upgraded (TEVA) to Buy on, Feb 14th, 2019

Elliot Wilbur of Raymond James, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy on, Feb 14th, 2019.

Elliot has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Elliot's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019


These are the ratings of the 2 analyists that currently disagree with Elliot

  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018